These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2074088)

  • 1. Plasma insulin-like growth factor I levels during treatment of congenital adrenal hyperplasia.
    Cavallo A; Furlanetto RW; Meyer WJ
    Horm Res; 1990; 34(1):23-6. PubMed ID: 2074088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin and insulin-like growth factor I levels in children with congenital adrenal hyperplasia.
    Hargitai G; Hosszú E; Halász Z; Sólyom J
    Horm Res; 1999; 52(3):131-9. PubMed ID: 10725777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different states of clinical control are associated with changes in IGF-I and IGFBPs in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Cunha HM; Elias LL; Camacho-Hübner C; Moreira AC; Martinelli CE
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):94-101. PubMed ID: 15212650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
    Völkl TM; Rauh M; Schöfl C; Dörr HG
    Growth Horm IGF Res; 2011 Aug; 21(4):191-8. PubMed ID: 21636299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
    J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S; Sellers EA; Guyda H;
    J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone treatment in girls with congenital adrenal hyperplasia inhibits serum dehydroepiandrosterone sulfate and affects the GH-IGF-I system.
    Guercio G; Rivarola MA; Chaler E; Maceiras M; Belgorosky A
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):255-61. PubMed ID: 19492582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ; Goossens K; Setyawati BA; Drop SL; de Jong FH; Faradz SM
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE; Sizonenko PC
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
    Armengaud JB; Charkaluk ML; Trivin C; Tardy V; Bréart G; Brauner R; Chalumeau M
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2835-40. PubMed ID: 19454583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
    Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of plasma androstenedione in monitoring therapy of patients with congenital adrenal hyperplasia.
    Cavallo A; Corn C; Bryan GT; Meyer WJ
    J Pediatr; 1979 Jul; 95(1):33-7. PubMed ID: 480011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia.
    Sarafoglou K; Zimmerman CL; Gonzalez-Bolanos MT; Willis BA; Brundage R
    J Investig Med; 2015 Jan; 63(1):35-41. PubMed ID: 25386671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A; Rivarola MA
    Horm Res; 1998; 49(5):226-32. PubMed ID: 9568807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of androstenedione levels by an in-house radioimmunoassay.
    Lo MS; Ng ML; Wu LL; Khalid BA
    Malays J Pathol; 1996 Jun; 18(1):53-8. PubMed ID: 10879225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA; Urban MD; Gutai JP; Migeon CJ
    Horm Res; 1980; 13(6):347-57. PubMed ID: 7196877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-related effects on peripheral glucose metabolism in women with congenital adrenal hyperplasia.
    Paula FJ; Gouveia LM; Paccola GM; Piccinato CE; Moreira AC; Foss MC
    Horm Metab Res; 1994 Nov; 26(11):552-6. PubMed ID: 7875653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.